Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet - excipient ingredients: colloidal anhydrous silica; calcium hydrogen phosphate; hypromellose; polysorbate 80; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.

United States - English - NLM (National Library of Medicine)

emergent biosolutions canada inc. - equine botulinum neurotoxin a immune fab2 (unii: le3j6i6dxp) (equine botulinum neurotoxin a immune fab2 - unii:le3j6i6dxp), equine botulinum neurotoxin b immune fab2 (unii: vsk09vp4hl) (equine botulinum neurotoxin b immune fab2 - unii:vsk09vp4hl), equine botulinum neurotoxin c immune fab2 (unii: x5i2p7e9ty) (equine botulinum neurotoxin c immune fab2 - unii:x5i2p7e9ty), equine botulinum neurotoxin d immune fab2 (unii: 30y9n0sebe) (equine botulinum neurotoxin d immune fab2 - unii:30y9n0sebe), equine botul - equine botulinum neurotoxin a immune fab2 4500 [iu] in 10 ml - bat [botulism antitoxin heptavalent (a, b, c, d, e, f, g) – (equine)] is a mixture of immune globulin fragments indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes a, b, c, d, e, f, or g in adults and pediatric patients. the effectiveness of bat is based on efficacy studies conducted in animal models of botulism. none. risk summary there are no human or animal data to establish the presence or absence of bat associated risk. risk summary there are no data to assess the presence or absence of bat in human milk, the effects on the breastfed child or the effects on milk production/excretion. consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for bat and any potential adverse effects on the breastfed child from bat or from the underlying maternal condition. the effectiveness of bat has not been established in pediatric patients. limited pediatric safety data are available. fifteen pediat

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - equine rotavirus h2 strain - emulsion for injection - . - equine rotavirus - horses - immunological - inactivated vaccine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dopharma (research) n.v. - flumequine 500 mg/g - powder for oral solution - 500 mg/g - flumequine 500 mg/g - flumequine - poultry; cattle

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale sa-nv - flumequine 50 g/100 g - oral powder - 50 % - flumequine 500 mg/g - flumequine - poultry; cattle; pig

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale sa-nv - flumequine 100 mg/ml - oral solution - 10 % - flumequine 100 mg/ml - flumequine - poultry; cattle

United Kingdom - English - VMD (Veterinary Medicines Directorate)

veterinary immunogenics ltd - equine plasma, rhodococcus equi - solution for infusion - serum - horses

Philippines - English - FDA (Food And Drug Administration)

advira trading corporation; distributor: advira trading corporation - equine infectious anemia (eia) virus immunodiffusion test - na - na

Australia - English - Department of Health (Therapeutic Goods Administration)

immunoglobulin - antithymocyte (equine) -

United States - English - NLM (National Library of Medicine)

epicare limited - arginine (unii: 94zla3w45f) (arginine - unii:94zla3w45f), aminobenzoic acid (unii: tl2tje8qtx) (aminobenzoic acid - unii:tl2tje8qtx) - contains: arginine aminobenzoate 2.5% patent # 5734080 in a cream base with  safflower oil, apricot kernel oil, mixed tocopherols, glycerin, coconut oil, borage oil, tea tree  oil, camphor, lecithin, grapefruit extract and aloe vera. directions: apply topically as needed to minor wounds and skin lesions. indications for  use: equineaid can be used on minor cuts, abrasions and irritations as well as superficial wounds and skin lesions on horses. avoid contact with eyes. if contact occurs, flush with copious amounts of water. if condition persists, redness or irritation occurs, discontinue use. shake well store at room temperature. for veterinary use only